Mid American Wealth Advisory Group, Inc. Cabaletta Bio, Inc. Transaction History
Mid American Wealth Advisory Group, Inc.
- $210 Billion
- Q2 2025
A detailed history of Mid American Wealth Advisory Group, Inc. transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Mid American Wealth Advisory Group, Inc. holds 91 shares of CABA stock, worth $222. This represents 0.0% of its overall portfolio holdings.
Number of Shares
91Holding current value
$222% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CABA
# of Institutions
94Shares Held
77.1MCall Options Held
406KPut Options Held
90.9K-
Bain Capital Life Sciences Investors, LLC Boston, MA9.68MShares$23.6 Million4.41% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.83MShares$21.5 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.79MShares$16.6 Million0.01% of portfolio
-
Jennison Associates LLC6.02MShares$14.7 Million0.01% of portfolio
-
Cormorant Asset Management, LP Boston, MA5MShares$12.2 Million0.77% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $70.8M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...